| Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression DJ David, BA Samuels, Q Rainer, JW Wang, D Marsteller, I Mendez, ... Neuron 62 (4), 479-493, 2009 | 1395 | 2009 |
| Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors U Maskos, BE Molles, S Pons, M Besson, BP Guiard, JP Guilloux, ... Nature 436 (7047), 103-107, 2005 | 686 | 2005 |
| 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants JW Richardson-Jones, CP Craige, BP Guiard, A Stephen, KL Metzger, ... Neuron 65 (1), 40-52, 2010 | 504 | 2010 |
| Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions BP Guiard, M El Mansari, Z Merali, P Blier International Journal of Neuropsychopharmacology 11 (5), 625-639, 2008 | 315 | 2008 |
| Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats AM Coelho, N Vergnolle, B Guiard, J Fioramonti, L Bueno Gastroenterology 122 (4), 1035-1047, 2002 | 259 | 2002 |
| BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities G Quesseveur, DJ David, MC Gaillard, P Pla, MV Wu, HT Nguyen, ... Translational psychiatry 3 (4), e253-e253, 2013 | 242 | 2013 |
| Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety JW Richardson-Jones, CP Craige, TH Nguyen, HF Kung, AM Gardier, ... Journal of Neuroscience 31 (16), 6008-6018, 2011 | 232 | 2011 |
| Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice T Deltheil, BP Guiard, J Cerdan, DJ David, KF Tanaka, C Repérant, ... Neuropharmacology 55 (6), 1006-1014, 2008 | 195 | 2008 |
| The menace of obesity to depression and anxiety prevalence S Fulton, L Décarie-Spain, X Fioramonti, B Guiard, S Nakajima Trends in Endocrinology & Metabolism 33 (1), 18-35, 2022 | 190 | 2022 |
| Relevance of norepinephrine–dopamine interactions in the treatment of major depressive disorder M El Mansari, BP Guiard, O Chernoloz, R Ghanbari, N Katz, P Blier CNS neuroscience & therapeutics 16 (3), e1-e17, 2010 | 190 | 2010 |
| High‐fat diet‐induced metabolic disorders impairs 5‐HT function and anxiety‐like behavior in mice J Zemdegs, G Quesseveur, D Jarriault, L Pénicaud, X Fioramonti, ... British journal of pharmacology 173 (13), 2095-2110, 2016 | 180 | 2016 |
| Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus BP Guiard, M El Mansari, P Blier Molecular pharmacology 74 (5), 1463-1475, 2008 | 162 | 2008 |
| Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response A Bacq, L Balasse, G Biala, B Guiard, AM Gardier, A Schinkel, F Louis, ... Molecular psychiatry 17 (9), 926-939, 2012 | 155 | 2012 |
| Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice JP Guilloux, I Mendez-David, A Pehrson, BP Guiard, C Repérant, ... Neuropharmacology 73, 147-159, 2013 | 148 | 2013 |
| Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link? BP Guiard, GD Giovanni Frontiers in Pharmacology 6, 134753, 2015 | 133 | 2015 |
| Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice TH Pham, I Mendez-David, C Defaix, BP Guiard, L Tritschler, DJ David, ... Neuropharmacology 112, 198-209, 2017 | 131 | 2017 |
| Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids J Zemdegs, H Martin, H Pintana, S Bullich, S Manta, MA Marqués, C Moro, ... Journal of Neuroscience 39 (30), 5935-5948, 2019 | 119 | 2019 |
| Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors BP Guiard, ME Mansari, P Blier Current drug targets 10 (11), 1069-1084, 2009 | 100 | 2009 |
| 5-HT2 ligands in the treatment of anxiety and depression G Quesseveur, HT Nguyen, AM Gardier, BP Guiard Expert opinion on investigational drugs 21 (11), 1701-1725, 2012 | 80 | 2012 |
| A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain D Popa, J Cerdan, C Repérant, BP Guiard, JP Guilloux, DJ David, ... European journal of pharmacology 628 (1-3), 83-90, 2010 | 80 | 2010 |
